Mycological Testing Market - Global Opportunity Analysis and Industry Forecast, 2020-2027
|
LI_184849
|
Pages: NA
|
Mar 2020 |
474 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4 MYCOLOGICAL TESTING MARKET, BY TECHNOLOGY
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ELISA
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast by region
4.2.3. Market size and forecast by country
4.3. RAPID TESTS
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast by region
4.3.3. Market size and forecast by country
4.4. ELISPOT
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast by region
4.4.3. Market size and forecast by country
4.5. POLYMERASE CHAIN REACTION (PCR)
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast by region
4.5.3. Market size and forecast by country
CHAPTER 5 MYCOLOGICAL TESTING MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Market size and forecast by region
5.2.2. Market size and forecast by country
5.3. CLINICAL LABORATORIES
5.3.1. Market size and forecast by region
5.3.2. Market size and forecast by country
5.4. RESEARCH CENTERS
5.4.1. Market size and forecast by region
5.4.2. Market size and forecast by country
5.5. OTHERS
5.5.1. Market size and forecast by region
5.5.2. Market size and forecast by country
CHAPTER 6 MYCOLOGICAL TESTING MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends, growth factors and opportunities
6.2.2. North America mycological testing market, by country
6.2.2.1. U.S. mycological testing market
6.2.2.1.1. U.S. market, by technology
6.2.2.1.2. U.S. market, by end user
6.2.2.2. Canada mycological testing market
6.2.2.2.1. Canada market, by technology
6.2.2.2.2. Canada market, by end user
6.2.2.3. Mexico mycological testing market
6.2.2.3.1. Mexico market, by technology
6.2.2.3.2. Mexico market, by end user
6.2.3. North America mycological testing market, by technology
6.2.4. North America mycological testing market, by end user
6.3. EUROPE
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Europe Mycological testing market, by country
6.3.2.1. Germany mycological testing market
6.3.2.1.1. Germany market, by technology
6.3.2.1.2. Germany market, by end user
6.3.2.2. France mycological testing market
6.3.2.2.1. France market, by technology
6.3.2.2.2. France market, by end user
6.3.2.3. UK mycological testing market
6.3.2.3.1. UK market, by technology
6.3.2.3.2. UK market, by end user
6.3.2.4. Italy mycological testing market
6.3.2.4.1. Italy market, by technology
6.3.2.4.2. Italy market, by end user
6.3.2.5. Spain mycological testing market
6.3.2.5.1. Spain market, by technology
6.3.2.5.2. Spain market, by end user
6.3.2.6. Rest of Europe mycological testing market
6.3.2.6.1. Rest of Europe market, by technology
6.3.2.6.2. Rest of Europe market, by end user
6.3.3. Europe mycological testing market, by technology
6.3.4. Europe mycological testing market, by end user
6.4. ASIA-PACIFIC
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Asia-Pacific Mycological testing market, by country
6.4.2.1. Japan mycological testing market
6.4.2.1.1. Japan market, by technology
6.4.2.1.2. Japan market, by end user
6.4.2.2. China mycological testing market
6.4.2.2.1. China market, by technology
6.4.2.2.2. China market, by end user
6.4.2.3. Australia mycological testing market
6.4.2.3.1. Australia market, by technology
6.4.2.3.2. Australia market, by end user
6.4.2.4. India mycological testing market
6.4.2.4.1. India market, by technology
6.4.2.4.2. India market, by end user
6.4.2.5. South Korea mycological testing market
6.4.2.5.1. South Korea market, by technology
6.4.2.5.2. South Korea market, by end user
6.4.2.6. Rest of Asia-Pacific mycological testing market
6.4.2.6.1. Rest of Asia-Pacific market, by technology
6.4.2.6.2. Rest of Asia-Pacific market, by end user
6.4.3. Asia-Pacific mycological testing market, by technology
6.4.4. Asia-Pacific mycological testing market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. LAMEA Mycological testing market, by country
6.5.2.1. Brazil mycological testing market
6.5.2.1.1. Brazil market, by technology
6.5.2.1.2. Brazil market, by end user
6.5.2.2. Saudi Arabia mycological testing market
6.5.2.2.1. Saudi Arabia market, by technology
6.5.2.2.2. Saudi Arabia market, by end user
6.5.2.3. South Africa mycological testing market
6.5.2.3.1. South Africa market, by technology
6.5.2.3.2. South Africa market, by end user
6.5.2.4. Rest of LAMEA mycological testing market
6.5.2.4.1. Rest of LAMEA market, by technology
6.5.2.4.2. Rest of LAMEA market, by end user
6.5.3. LAMEA mycological testing market, by technology
6.5.4. LAMEA mycological testing market, by end user
CHAPTER 7 COMPANY PROFILES
7.1. F. HOFFMANN-LA ROCHE LTD
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. ABBOTT LABORATORIES, INC.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. SIEMENS AG
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. BECKMAN COULTER, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ORTHO-CLINICAL DIAGNOSTICS, INC.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. BIOMÉRIEUX SA
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. ELITECHGROUP
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. MIRAVISTA DIAGNOSTICS
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. ALS
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. BCN RESEARCH LABORATORIES, INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Mycological Testing Market- Global Opportunity Analysis and Industry Forecast, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $559 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.